<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01833598</url>
  </required_header>
  <id_info>
    <org_study_id>GCO 12-0656</org_study_id>
    <secondary_id>HSS 2015-189</secondary_id>
    <nct_id>NCT01833598</nct_id>
  </id_info>
  <brief_title>Percutaneous Needle Tenotomy (PNT) Versus Platelet Rich Plasma (PRP) With PNT in the Treatment of Chronic Tendinosis</brief_title>
  <official_title>The Efficacy of Ultrasound Guided Percutaneous Needle Tenotomy (PNT) Versus Platelet Rich Plasma (PRP) With PNT in the Treatment of Chronic Tendinosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital for Special Surgery, New York</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital for Special Surgery, New York</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tendinopathy is a clinical syndrome of chronic pain and tendon degeneration that impairs a
      person's ability to perform daily activities and recreation. Traditional conservative
      treatments include activity modification, exercises, ice/heat, and medications and
      corticosteroid injection. A newer treatment is percutaneous needle tenotomy (PNT), in which
      the affected area is repetitively needled to disrupt pathological tissue and induce bleeding.
      This turns a nonhealing chronic injury into an acute injury with enhanced healing capability.
      Another is Platelet Rich Plasma (PRP), whereby patients' own platelets are injected into the
      affected area, also activating growth factors. There has been promising research in these
      tendinopathy treatments but more research is needed.

      The investigators plan to expand on prior studies to identify a reproducible and efficacious
      treatment for chronic tendinopathy to reduce pain and improve function and quality of life.
      Our goal in this study is to assess the efficacy of ultrasound guided (USG) PNT versus PNT
      with peritendinous PRP as a treatment for chronic tendinopathy.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 2012</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>Week 2</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>Week 4</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>Week 6</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>Week 8</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>Week 12</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Activity Level</measure>
    <time_frame>Week 2</time_frame>
    <description>Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activity Level</measure>
    <time_frame>Week 4</time_frame>
    <description>Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activity Level</measure>
    <time_frame>Week 6</time_frame>
    <description>Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activity Level</measure>
    <time_frame>Week 8</time_frame>
    <description>Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activity Level</measure>
    <time_frame>Week 12</time_frame>
    <description>Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Week 2</time_frame>
    <description>bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Weeks 4</time_frame>
    <description>bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Weeks 6</time_frame>
    <description>bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Weeks 8</time_frame>
    <description>bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Weeks 12</time_frame>
    <description>bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Chronic Tendinopathy</condition>
  <arm_group>
    <arm_group_label>PNT + PRP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>percutaneous needle tenotomy with peritendinous platelet-rich plasma injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PNT alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>percutaneous needle tenotomy alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PNT + PRP</intervention_name>
    <description>The PNT + PRP group will undergo needle tenotomy under direct and continuous ultrasound guidance with even distribution of PRP into the peritendinous area(s) of PNT around the affected tendon.</description>
    <arm_group_label>PNT + PRP</arm_group_label>
    <other_name>percutaneous needle tenotomy with peritendinous platelet-rich plasma injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PNT alone</intervention_name>
    <description>The PNT group will undergo needle tenotomy under direct and continuous ultrasound guidance local anesthesia into the affected tendon. 10 minutes after the injection, the ultrasound machine probe will be passed over the areas treated both to evaluate for any structural changes and for any complications.</description>
    <arm_group_label>PNT alone</arm_group_label>
    <other_name>percutaneous needle tenotomy alone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged 18-100 years

          -  pain (≥ 5/10 pain on the VAS) that is a direct result of tendinosis as determined by
             history of injury and study team member physician's best judgment and review of
             medical records, imaging studies, etc.

          -  Tendinosis will be confirmed by clinical and ultrasonographic examination by the PI

          -  ≥3 months of pain after injury that has failed conservative treatments or after
             corticosteroid (CSI) (must be 3 months after CSI to avoid theoretical tendon rupture)

        Exclusion Criteria:

          -  taking coumadin or other anti-coagulant or anti-platelet medication

          -  known coagulopathy or bleeding dyscrasia

          -  current or recent fluoroquinolone prescription

          -  prior PNT or PRP for the affected tendon(s)

          -  known systemic illness such as vasculitis, an autoimmune or an inflammatory disease,
             or uncontrolled diabetes

          -  presence of other musculoskeletal injury or tendon rupture in the region

          -  currently are or plan to become pregnant during the study.

               -  Patients taking aspirin or NSAIDs are not excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan Kirschner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital for Special Surgery, New York</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kaux JF, Forthomme B, Goff CL, Crielaard JM, Croisier JL. Current opinions on tendinopathy. J Sports Sci Med. 2011 Jun 1;10(2):238-53. Review.</citation>
    <PMID>24149868</PMID>
  </reference>
  <reference>
    <citation>Scott A, Ashe MC. Common tendinopathies in the upper and lower extremities. Curr Sports Med Rep. 2006 Sep;5(5):233-41. Review.</citation>
    <PMID>16934204</PMID>
  </reference>
  <reference>
    <citation>Fredberg U, Stengaard-Pedersen K. Chronic tendinopathy tissue pathology, pain mechanisms, and etiology with a special focus on inflammation. Scand J Med Sci Sports. 2008 Feb;18(1):3-15. doi: 10.1111/j.1600-0838.2007.00746.x. Review.</citation>
    <PMID>18294189</PMID>
  </reference>
  <reference>
    <citation>Struijs PA, Kerkhoffs GM, Assendelft WJ, Van Dijk CN. Conservative treatment of lateral epicondylitis: brace versus physical therapy or a combination of both-a randomized clinical trial. Am J Sports Med. 2004 Mar;32(2):462-9.</citation>
    <PMID>14977675</PMID>
  </reference>
  <reference>
    <citation>Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010 Nov 20;376(9754):1751-67. doi: 10.1016/S0140-6736(10)61160-9. Epub 2010 Oct 21. Review.</citation>
    <PMID>20970844</PMID>
  </reference>
  <reference>
    <citation>McShane JM, Shah VN, Nazarian LN. Sonographically guided percutaneous needle tenotomy for treatment of common extensor tendinosis in the elbow: is a corticosteroid necessary? J Ultrasound Med. 2008 Aug;27(8):1137-44.</citation>
    <PMID>18645071</PMID>
  </reference>
  <reference>
    <citation>McShane JM, Nazarian LN, Harwood MI. Sonographically guided percutaneous needle tenotomy for treatment of common extensor tendinosis in the elbow. J Ultrasound Med. 2006 Oct;25(10):1281-9.</citation>
    <PMID>16998100</PMID>
  </reference>
  <reference>
    <citation>Housner JA, Jacobson JA, Misko R. Sonographically guided percutaneous needle tenotomy for the treatment of chronic tendinosis. J Ultrasound Med. 2009 Sep;28(9):1187-92.</citation>
    <PMID>19710216</PMID>
  </reference>
  <reference>
    <citation>Skjong CC, Meininger AK, Ho SS. Tendinopathy treatment: where is the evidence? Clin Sports Med. 2012 Apr;31(2):329-50. doi: 10.1016/j.csm.2011.11.003.</citation>
    <PMID>22341021</PMID>
  </reference>
  <reference>
    <citation>Maffulli N, Longo UG, Denaro V. Novel approaches for the management of tendinopathy. J Bone Joint Surg Am. 2010 Nov 3;92(15):2604-13. doi: 10.2106/JBJS.I.01744. Review.</citation>
    <PMID>21048180</PMID>
  </reference>
  <reference>
    <citation>Paavola M, Kannus P, Järvinen TA, Järvinen TL, Józsa L, Järvinen M. Treatment of tendon disorders. Is there a role for corticosteroid injection? Foot Ankle Clin. 2002 Sep;7(3):501-13. Review.</citation>
    <PMID>12512406</PMID>
  </reference>
  <reference>
    <citation>Bahr R, Fossan B, Løken S, Engebretsen L. Surgical treatment compared with eccentric training for patellar tendinopathy (Jumper's Knee). A randomized, controlled trial. J Bone Joint Surg Am. 2006 Aug;88(8):1689-98.</citation>
    <PMID>16882889</PMID>
  </reference>
  <reference>
    <citation>Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R. 2011 Mar;3(3):226-50. doi: 10.1016/j.pmrj.2010.11.007. Review.</citation>
    <PMID>21402369</PMID>
  </reference>
  <reference>
    <citation>Finnoff JT, Fowler SP, Lai JK, Santrach PJ, Willis EA, Sayeed YA, Smith J. Treatment of chronic tendinopathy with ultrasound-guided needle tenotomy and platelet-rich plasma injection. PM R. 2011 Oct;3(10):900-11. doi: 10.1016/j.pmrj.2011.05.015. Epub 2011 Aug 26.</citation>
    <PMID>21872551</PMID>
  </reference>
  <reference>
    <citation>de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, Tol JL. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010 Jan 13;303(2):144-9. doi: 10.1001/jama.2009.1986.</citation>
    <PMID>20068208</PMID>
  </reference>
  <reference>
    <citation>de Jonge S, de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, Tol JL. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial. Am J Sports Med. 2011 Aug;39(8):1623-9. doi: 10.1177/0363546511404877. Epub 2011 May 21.</citation>
    <PMID>21602565</PMID>
  </reference>
  <reference>
    <citation>Filardo G, Kon E, Della Villa S, Vincentelli F, Fornasari PM, Marcacci M. Use of platelet-rich plasma for the treatment of refractory jumper's knee. Int Orthop. 2010 Aug;34(6):909-15. doi: 10.1007/s00264-009-0845-7. Epub 2009 Jul 31.</citation>
    <PMID>19641918</PMID>
  </reference>
  <reference>
    <citation>Kon E, Filardo G, Delcogliano M, Presti ML, Russo A, Bondi A, Di Martino A, Cenacchi A, Fornasari PM, Marcacci M. Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee. Injury. 2009 Jun;40(6):598-603. doi: 10.1016/j.injury.2008.11.026. Epub 2009 Apr 19.</citation>
    <PMID>19380129</PMID>
  </reference>
  <reference>
    <citation>Naredo E, Cabero F, Beneyto P, Cruz A, Mondéjar B, Uson J, Palop MJ, Crespo M. A randomized comparative study of short term response to blind injection versus sonographic-guided injection of local corticosteroids in patients with painful shoulder. J Rheumatol. 2004 Feb;31(2):308-14.</citation>
    <PMID>14760802</PMID>
  </reference>
  <reference>
    <citation>Rutten MJ, Maresch BJ, Jager GJ, de Waal Malefijt MC. Injection of the subacromial-subdeltoid bursa: blind or ultrasound-guided? Acta Orthop. 2007 Apr;78(2):254-7.</citation>
    <PMID>17464615</PMID>
  </reference>
  <reference>
    <citation>Wolf JM, Ozer K, Scott F, Gordon MJ, Williams AE. Comparison of autologous blood, corticosteroid, and saline injection in the treatment of lateral epicondylitis: a prospective, randomized, controlled multicenter study. J Hand Surg Am. 2011 Aug;36(8):1269-72. doi: 10.1016/j.jhsa.2011.05.014. Epub 2011 Jun 25.</citation>
    <PMID>21705157</PMID>
  </reference>
  <reference>
    <citation>Creaney L, Wallace A, Curtis M, Connell D. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med. 2011 Sep;45(12):966-71. doi: 10.1136/bjsm.2010.082503. Epub 2011 Mar 15.</citation>
    <PMID>21406450</PMID>
  </reference>
  <reference>
    <citation>Kaux JF, Le Goff C, Seidel L, Péters P, Gothot A, Albert A, Crielaard JM. [Comparative study of five techniques of preparation of platelet-rich plasma]. Pathol Biol (Paris). 2011 Jun;59(3):157-60. doi: 10.1016/j.patbio.2009.04.007. Epub 2009 May 28. French.</citation>
    <PMID>19481375</PMID>
  </reference>
  <reference>
    <citation>Koh ES, Williams AJ, Povlsen B. Upper-limb pain in long-term poliomyelitis. QJM. 2002 Jun;95(6):389-95.</citation>
    <PMID>12037247</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2013</study_first_submitted>
  <study_first_submitted_qc>April 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2013</study_first_posted>
  <last_update_submitted>January 11, 2018</last_update_submitted>
  <last_update_submitted_qc>January 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic tendinopathy</keyword>
  <keyword>platelet rich plasma</keyword>
  <keyword>tendonitis</keyword>
  <keyword>percutaneous tendon tenotomy</keyword>
  <keyword>pain</keyword>
  <keyword>shoulder</keyword>
  <keyword>knee</keyword>
  <keyword>ankle</keyword>
  <keyword>foot</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

